A study of influence of progesterone on activity of Glycoprotein-P in vitro
Open Access
- 3 July 2020
- journal article
- research article
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 28 (2) , 135-142
Abstract
Background. Glycoprotein-P (Pgp, АВСВ1) is a transporter protein participating in pharmacokinetics of medical drugs, and also in development of resistance of tumor cells to chemotherapy. Aim. To study the influence of progesterone on the activity of Pgp in vitro on a cell model of human small intestinal epithelium. Materials and Methods. The work was conducted on Caco-2 cells. The activity of Pgp was evaluated by transport of fexofenadine in a special transwell-system. Concentration of fexofenadine was analyzed by HPLC method. The amount of Pgp was determined by EIA method. Four series of experiments were conducted: control cells preincubated with clean transport medium without addition of any substances; influence of rifampicin on the activity and synthesis of Pgp in the concentration 10 mol/l in preincubation for 3 days (induction control); influence of progesterone on the activity of Pgp in concentrations 1, 10 and 100 mol/l in preincubation for 30 min; influence of progesterone on the activity and synthesis of Pgp in concentrations 1, 10 and 100 mol/l in preincubation for 3 days. Results. Progesterone in the concentrations 1 and 10 M in incubation with cells within 30 minutes did not show any reliable influence on the activity of Pgp, however, in concentration 100 M it reduced the activity of the transporter protein. In incubation of Caco-2 cells with progesterone in concentrations 1, 10 and 100 M within 3 days the activity of Pgp remained unchanged. Progesterone in concentration 100 M in incubation within 3 days significantly increased synthesis of Pgp in enterocytes by 114.3% as compared to control, and in other used concentrations (1 and 10 M) it produced no reliable effect. Conclusion. In in vitro experiments on Caco-2 cells progesterone in concentration 100 M produces a direct inhibiting effect on the activity of Pgp; however, in incubation within 3 days it increases synthesis of the transporter protein, which cancels out its inhibitory activity.Keywords
This publication has 7 references indexed in Scilit:
- Влияние прогестерона на функциональную активность гликопротеина-P в экспериментеХимико-фармацевтический журнал, 2018
- Estradiol and Progesterone-Mediated Regulation of P-gp in P-gp Overexpressing Cells (NCI-ADR-RES) and Placental Cells (JAR)Molecular Pharmaceutics, 2009
- Validation and application of Caco-2 assays for thein vitroevaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissionsXenobiotica, 2008
- Effects of Progesterone and Norethisterone on Cephalexin Transport and Peptide Transporter PEPT1 Expression in Human Intestinal Cell Line Caco-2Biological and Pharmaceutical Bulletin, 2006
- In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestinsBiochemical Pharmacology, 2004
- Transport Characteristics of Fexofenadine in the Caco-2 Cell ModelPharmaceutical Research, 2004
- An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling PathwayCell, 1998